Investors who purchased POET Technologies stock between April 1 and April 27, 2026, face potential financial losses following a class action lawsuit filed by the Schall Law Firm. The legal action alleges that the company violated federal securities laws by misrepresenting its tax status and internal business conduct.
Investors who purchased Immutep Limited shares between March 24, 2025, and March 12, 2026, are being urged to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the efficacy of its TACTI-004 clinical trial for the drug eftilagimod alfa.
Investors who purchased POET Technologies shares between April 1 and April 27, 2026, face a critical window to join a class action lawsuit. The DJS Law Group is currently organizing plaintiffs to address allegations that the company misled the market regarding its tax status as a passive foreign investment entity.
Investors who purchased Commvault Systems stock between April 29, 2025, and January 26, 2026, are being urged to join a class action lawsuit against the company. The Schall Law Firm alleges that Commvault misled the market regarding its annual recurring revenue growth during that period, causing significant financial losses.
Investors who purchased Immutep Limited securities between March 24, 2025, and March 12, 2026, face a critical window to join a class action lawsuit against the company. The Schall Law Firm is spearheading the litigation, alleging that the biotech firm misled shareholders regarding the results of its TACTI-004 clinical trial.
Investors who purchased Graphic Packaging Holding Company stock between February 4, 2025, and February 2, 2026, are facing a legal deadline of July 6, 2026, to join a class action lawsuit alleging the firm misled the market regarding inventory management, operational costs, and declining consumer demand.
Investors who purchased Globant S.A. shares between February 15, 2024, and August 14, 2025, face a June 23, 2026, deadline to join a class action lawsuit. The litigation alleges the company misled the market regarding the actual success of its strategic Latin American pivot.
Shareholders who acquired Globant S.A. securities between February 15, 2024, and August 14, 2025, face a critical deadline to join a class action lawsuit. The Schall Law Firm is currently organizing the case, alleging that the technology company misled the market regarding its strategic performance and internal stability during this period.
A federal class action lawsuit now targets SES AI Corporation, alleging the battery technology developer artificially inflated its financial standing. The complaint centers on claims that the company disguised service payments as revenue, misleading shareholders regarding the true performance of its Molecular Universe platform throughout early 2025 and 2026.
The Board of Directors at Sivers Semiconductors AB abruptly pulled three key items from its 2026 Annual General Meeting agenda today. The decision, announced in Kista, Sweden, halts immediate voting on proposed employee incentive programs to ensure the incoming board has a direct role in shaping the company's compensation strategy.
Shenzhen-based fitness technology firm Speediance has signed a deal to become the official smart equipment partner of the ATHX competition series through December 2027. The agreement places the company’s portable Gym Nano resistance system at the center of athlete warm-up and recovery zones across 57 international events.
Lundbeck’s investigational antibody asedebart has shown promise in treating Cushing’s disease, with early Phase II trial results indicating successful normalization of urinary free cortisol levels in the vast majority of evaluable patients, according to data presented at the 2026 Endocrine Society’s Annual Meeting in Chicago.
A thousand-euro drone crippling a multi-million-euro asset has become the new baseline for modern combat. As Eurosatory 2026 opens in Paris, tech firm Sopra Steria argues that military superiority no longer rests on platform power, but on the relentless speed of data processing and the ability to absorb saturation.
With the acquisition of a controlling interest in Genesis Digital Assets, Euronext Amsterdam-listed SWI Group is aggressively expanding its footprint into the United States. The deal adds 1.3 GW of energized capacity to the firm’s portfolio, positioning the conglomerate as a major player in the global AI and high-performance computing race.
With a $500 million acquisition of a significant stake in Genesis Digital Assets, SWI Group is pivoting a massive 1.3 GW American portfolio away from cryptocurrency mining. The move signals a strategic shift toward high-performance computing, positioning the firm to command a transatlantic footprint of 3.6 GW for AI workloads.
With the acquisition of a majority stake in Genesis Digital Assets, the London and Amsterdam-based SWI Group is aggressively expanding its footprint into the United States. This move secures 1.3 gigawatts of energized grid capacity, positioning the conglomerate to pivot toward high-performance computing and heavy AI-driven workloads.
Munich's Intersolar Europe exhibition will host ZTT from June 23–25, 2026, as the company prepares to demonstrate its end-to-end capabilities in the renewable sector. Operating from booth C3.480, the firm plans to highlight its expanded ecosystem of solar, energy storage, and hydrogen technologies designed for global grid modernization.
A drone costing a few thousand euros now routinely neutralizes equipment worth millions, forcing European military planners to abandon the pursuit of expensive platforms in favor of speed and data. As Eurosatory 2026 opens, Sopra Steria’s latest trend book argues that strategic autonomy has shifted from a distant ambition to an immediate necessity.
London-based SWI Group has secured a significant stake in Genesis Digital Assets Limited for $500 million, pivoting 1.3 gigawatts of American power infrastructure away from cryptocurrency mining toward high-performance computing and artificial intelligence, a move that pushes the firm’s total transatlantic capacity to 3.6 gigawatts.
Seven out of eight evaluable patients achieved normalized cortisol levels during a Phase II trial of asedebart, a novel monoclonal antibody targeting adrenocorticotropic hormone. The findings, presented at the Endocrine Society's annual meeting in Chicago, offer a potential new therapeutic path for treating the underlying causes of Cushing's disease.
As soccer season kicks off globally, oxygen therapy patients are finding that careful logistics and modern portable technology allow them to transition from home watch parties to live stadium environments without compromising their health or missing the excitement of the match.
Modern combat demands more than raw processing power; it requires rugged intelligence capable of surviving the front lines. At EUROSATORY 2026 in Paris, SINTRONES Technology Corp. is unveiling new tactical edge computing platforms designed to bring real-time AI inference and mission-critical data security directly into the field.
In the skies above Segovia, a new collaborative strike capability is taking shape as the Destinus Hornet interceptor successfully integrated Shield AI’s Hivemind software. The flight exercise represents a critical leap in neutralizing drone swarms and loitering munitions through autonomous coordination in contested airspace.
With 91% of executives linking electrification to national energy security, a new 18-country survey reveals that geopolitical volatility is forcing businesses to abandon fossil fuels. Leaders are no longer viewing the transition as a green initiative, but as a critical hedge against global instability and supply chain disruption.
Geopolitical instability has turned clean electrification from a climate goal into a survival strategy for the world's largest companies. A new survey of executives across 18 countries reveals that 91% view electrification as a critical pillar of energy security, with nearly eight in ten citing current global volatility as a catalyst for urgent change.
A new divide is reshaping the global workforce as companies leverage AI not just for automation, but as a force multiplier for human expertise. According to the 2026 PwC Global AI Jobs Barometer, businesses that integrate AI effectively are outpacing their peers in productivity, wage growth, and total headcount expansion.
Ten patients with recurrent glioblastoma have shown prolonged disease control after receiving RZ-001, a novel RNA-based gene therapy. Dr. Chae-Yong Kim of Seoul National University Bundang Hospital shared these interim results on June 13 at the Asian Society for Neuro-Oncology Annual Meeting in Kanazawa, Japan.
At AWE 2026, Ganzin Technology unveiled its Aurora ecosystem, a strategic supply chain framework designed to streamline the integration of eye-tracking into AI-enabled wearable devices. By coordinating optics, silicon, and reference hardware, the company aims to move attention-aware interfaces from niche prototypes to mass-market commercial production.
While 96% of chief marketing officers claim AI is fundamentally transforming their departments, a chasm remains between vision and reality. Most leaders are still relegating generative AI to minor task assistance rather than adopting the autonomous, multi-agent operating systems necessary to compete in a rapidly shifting consumer landscape.
Jim Dittman, the founder and chairman of Next Level Performance, has been selected as a 2026 NJBIZ Icon Honoree. The award recognizes veteran business leaders whose professional tenure and commitment to innovation have significantly influenced the commercial landscape across New Jersey over the past several decades.
